Hyogo, Japan

Fumio Yasuda

This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumio Yasuda. Retrieved from https://idiyas.com/inventor/fumio-yasuda-ihey1l5x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumio Yasuda: Innovator in Anti-Ulcer Agents

Introduction

Fumio Yasuda is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-ulcer agents. His innovative work has led to the creation of effective treatments that address critical health issues.

Latest Patents

Fumio Yasuda holds a patent for "Novel anti-ulcer agents and quassinoids." This patent focuses on highly effective anti-ulcer agents, specifically quassinoids, which are characterized by the formula: ##STR1## wherein R is hydrogen or hydroxy. This invention represents a significant advancement in the treatment of ulcers.

Career Highlights

Yasuda is associated with Shionogi Company Limited, a prominent pharmaceutical company known for its commitment to research and development. His work at Shionogi has allowed him to contribute to the advancement of medical science and improve patient outcomes.

Collaborations

Throughout his career, Fumio Yasuda has collaborated with esteemed colleagues, including Masami Doteuchi and Haruhiko Tada. These partnerships have fostered innovation and have been instrumental in the development of new therapeutic agents.

Conclusion

Fumio Yasuda's contributions to the field of anti-ulcer agents highlight his role as a key innovator in pharmaceuticals. His patent for quassinoids showcases his dedication to improving health outcomes through scientific research and collaboration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…